2010
DOI: 10.1016/j.fertnstert.2010.07.309
|View full text |Cite
|
Sign up to set email alerts
|

Validation and first clinical application of karyomapping for preimplantation diagnosis (PGD) of Gaucher disease combined with 24 chromosome screening

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…These results are applicable to performance of methods that require accurate genotyping and qualitative analysis of aneuploidy, such as those described by Johnson et al . (2010a) and Handyside et al . (2010) , or in situations where one might consider using WGA DNA to genotype-specific genes of interest (i.e.…”
Section: Resultsmentioning
confidence: 96%
See 1 more Smart Citation
“…These results are applicable to performance of methods that require accurate genotyping and qualitative analysis of aneuploidy, such as those described by Johnson et al . (2010a) and Handyside et al . (2010) , or in situations where one might consider using WGA DNA to genotype-specific genes of interest (i.e.…”
Section: Resultsmentioning
confidence: 96%
“…(2009 ) Treff et al . (2009b ) Handyside et al (2010 ) Chromosome translocation detection Johnson et al . (2010b ) Treff et al .…”
Section: Whole-genome Amplificationmentioning
confidence: 99%
“…Furthermore, the success of the specific methodologies evaluated in these studies cannot be considered applicable to all CCS technologies given the significant number of differences that exist. Once other unique modalities such as array CGH [16][17][18] and other SNP microarray approaches 12,19,20 are properly validated, it may be feasible to perform head-to-head trials comparing accuracy and clinical benefit.…”
Section: Randomized Controlled Trialmentioning
confidence: 99%
“…Although simultaneous aneuploidy (using mCGH [ 24 , 40 , 41 ] and SNP arrays [ 18 , 42 ]) and single gene (using conventional PCR) analysis has been reported, SNP array based haplotype methodologies provide the ability to avoid the time and expense of preparing PCR based family specific informative markers of the mutation but may be limited when additional family members are not available to define haplotype phases. A recent study illustrated the use of SNP arrays to predict inheritance of monogenic disease through haplotype based analysis [ 17 ] and has applied the methodology clinically [ 43 ]. Another group presented a similar application of SNP arrays with results confirmed from antenatal analysis of 3 pregnancies [ 44 ].…”
Section: Comprehensive Chromosome Screening (Ccs) Methodologiesmentioning
confidence: 99%